These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15622450)

  • 1. Monitoring of CD4+ and CD8+ T-cell responses after dendritic cell-based immunotherapy using CFSE dye dilution analysis.
    Putz T; Ramoner R; Gander H; Rahm A; Bartsch G; Höltl L; Thurnher M
    J Clin Immunol; 2004 Nov; 24(6):653-63. PubMed ID: 15622450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer.
    Chang AE; Redman BG; Whitfield JR; Nickoloff BJ; Braun TM; Lee PP; Geiger JD; Mulé JJ
    Clin Cancer Res; 2002 Apr; 8(4):1021-32. PubMed ID: 11948109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
    Hilchey SP; Bernstein SH
    Immunol Invest; 2007; 36(5-6):629-48. PubMed ID: 18161522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of a CFSE-based flow cytometry for evaluating EIAV-stimulated proliferation of T lymphocytes].
    Lin YZ; Deng XL; Shen N; Lü XL; Zhao LP; Kong XG; Shao YM; Zhou JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov; 24(11):1044-7. PubMed ID: 18992187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen.
    Gilliet M; Kleinhans M; Lantelme E; Schadendorf D; Burg G; Nestle FO
    Blood; 2003 Jul; 102(1):36-42. PubMed ID: 12560234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma model.
    Teitz-Tennenbaum S; Li Q; Davis MA; Chang AE
    Clin Immunol; 2008 Dec; 129(3):482-91. PubMed ID: 18845485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients.
    Lesterhuis WJ; De Vries IJ; Schreibelt G; Schuurhuis DH; Aarntzen EH; De Boer A; Scharenborg NM; Van De Rakt M; Hesselink EJ; Figdor CG; Adema GJ; Punt CJ
    Anticancer Res; 2010 Dec; 30(12):5091-7. PubMed ID: 21187495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope and HLA-type independent monitoring of antigen-specific T-cells after treatment with dendritic cells presenting full-length tumor antigens.
    Van Nuffel AM; Tuyaerts S; Benteyn D; Wilgenhof S; Corthals J; Heirman C; Neyns B; Thielemans K; Bonehill A
    J Immunol Methods; 2012 Mar; 377(1-2):23-36. PubMed ID: 22269772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dendritic cell-mediated immune responses among canine malignant cells.
    Tamura K; Arai H; Ueno E; Saito C; Yagihara H; Isotani M; Ono K; Washizu T; Bonkobara M
    J Vet Med Sci; 2007 Sep; 69(9):925-30. PubMed ID: 17917377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells.
    Höltl L; Rieser C; Papesh C; Ramoner R; Herold M; Klocker H; Radmayr C; Stenzl A; Bartsch G; Thurnher M
    J Urol; 1999 Mar; 161(3):777-82. PubMed ID: 10022683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous proliferation and type 2 cytokine secretion by CD4+T cells in patients with metastatic melanoma vaccinated with antigen-pulsed dendritic cells.
    Palucka AK; Connolly J; Ueno H; Kohl J; Paczesny S; Dhodapkar M; Fay J; Banchereau J
    J Clin Immunol; 2005 May; 25(3):288-95. PubMed ID: 15981095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions.
    Abate G; Eslick J; Newman FK; Frey SE; Belshe RB; Monath TP; Hoft DF
    J Infect Dis; 2005 Oct; 192(8):1362-71. PubMed ID: 16170753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elicitation of both CD4 and CD8 T-cell-mediated specific immune responses to HCA587 protein by autologous dendritic cells.
    Li B; He X; Pang X; Zhang H; Chen J; Chen W
    Scand J Immunol; 2004 Nov; 60(5):506-13. PubMed ID: 15541044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of CD4 T-cell responses to a tumor vaccine by cytokine flow cytometry.
    Maecker HT; Auffermann-Gretzinger S; Nomura LE; Liso A; Czerwinski DK; Levy R
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):902s-908s. PubMed ID: 11300490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.
    Aarntzen EH; De Vries IJ; Lesterhuis WJ; Schuurhuis D; Jacobs JF; Bol K; Schreibelt G; Mus R; De Wilt JH; Haanen JB; Schadendorf D; Croockewit A; Blokx WA; Van Rossum MM; Kwok WW; Adema GJ; Punt CJ; Figdor CG
    Cancer Res; 2013 Jan; 73(1):19-29. PubMed ID: 23087058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma.
    Qazilbash MH; Saini NY; Cha SC; Wang Z; Stadtmauer EA; Baladandayuthapani V; Lin H; Tross B; Honhar M; Rao SS; Kim K; Popescu M; Szymura S; Zhang T; Anderson A; Bashir Q; Shpall EJ; Orlowski RZ; Levine BL; Kerr N; Garfall A; Cohen A; Vogl DT; Dengel K; June CH; Champlin R; Kwak LW
    Blood; 2022 Mar; 139(9):1289-1301. PubMed ID: 34521108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
    Koido S; Hara E; Homma S; Torii A; Toyama Y; Kawahara H; Watanabe M; Yanaga K; Fujise K; Tajiri H; Gong J; Toda G
    Clin Cancer Res; 2005 Nov; 11(21):7891-900. PubMed ID: 16278414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preexisting antigen-specific immune responses are modulated by oral KLH feeding in humans.
    Hostmann A; Meyer T; Maul J; Preiss J; Boortz B; Thiel A; Duchmann R; Ullrich R
    Eur J Immunol; 2015 Jul; 45(7):1991-6. PubMed ID: 25847325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma.
    Kim JH; Lee Y; Bae YS; Kim WS; Kim K; Im HY; Kang WK; Park K; Choi HY; Lee HM; Baek SY; Lee H; Doh H; Kim BM; Kim CY; Jeon C; Jung CW
    Clin Immunol; 2007 Dec; 125(3):257-67. PubMed ID: 17916447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patients.
    Aarntzen EH; Schreibelt G; Bol K; Lesterhuis WJ; Croockewit AJ; de Wilt JH; van Rossum MM; Blokx WA; Jacobs JF; Duiveman-de Boer T; Schuurhuis DH; Mus R; Thielemans K; de Vries IJ; Figdor CG; Punt CJ; Adema GJ
    Clin Cancer Res; 2012 Oct; 18(19):5460-70. PubMed ID: 22896657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.